Aequim Alternative Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Aequim Alternative Investments’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,000	Closed	-$1.98M	–	105
2025 Q1	$1.98M	Buy	+15,000	New	+$1.87M	0.08%	78

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Aequim Alternative Investments's ITCI Position: Q2 2025 in Review

Aequim Alternative Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 15,000 shares — an estimated $1.98M sold.

Aequim Alternative Investments first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $1.98M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Aequim Alternative Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Aequim Alternative Investments sold 15,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.98M.
Aequim Alternative Investments first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Aequim Alternative Investments's Intra-Cellular Therapies Inc. position peaked at $1.98M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Aequim Alternative Investments's 13F filing for Q2 2025, filed 1 Aug 2025.